Diagnostic Utility of the International HIV Dementia Scale for HIVAssociated Neurocognitive Impairment and Disorder in South Africa

被引:19
作者
Goodkin, Karl [1 ,2 ]
Hardy, David J. [3 ,4 ]
Singh, Dinesh [5 ]
Lopez, Enrique [3 ,6 ]
机构
[1] AIDS Healthcare Fdn, Dept Mental Hlth, Los Angeles, CA 90027 USA
[2] E Tennessee State Univ, Quillen Coll Med, Dept Psychiat & Behav Sci, Johnson City, TN 37614 USA
[3] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
[4] Loyola Marymount Univ, Dept Psychol, Los Angeles, CA 90045 USA
[5] McCord Hosp, Dept Psychiat, Durban, South Africa
[6] Cedars Sinai Med Ctr, Dept Psychiat & Behav Neurosci, Los Angeles, CA 90048 USA
关键词
RAPID SCREENING-TEST; COGNITIVE IMPAIRMENT; INDIVIDUALS; PERFORMANCE; VALIDITY; UGANDA; HAART; RISK; AIDS; ERA;
D O I
10.1176/appi.neuropsych.13080178
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Studies in sub-Saharan Africa indicate that most HIV seropositive persons have HIV-associated neurocognitive disorder (HAND). HAND diagnosis is facilitated by specific screening. Seventy participants were recruited from an HIV voluntary counseling and testing clinic in Durban, South Africa. The diagnostic utility of the International HIV Dementia Scale (IHDS) was analyzed using a receiver operating characteristic (ROC) model. The ROC analysis comparing any HAND diagnosis (based on two neuropsychological tests) versus no diagnosis was statistically significant, with an optimal cut-off score of 10.5, sensitivity of 69%, and specificity of 74%. Sensitivity of the IHDS was highest for HIV-associated dementia.
引用
收藏
页码:352 / 358
页数:7
相关论文
共 34 条
  • [1] The use of "overall accuracy" to evaluate the validity of screening or diagnostic tests
    Alberg, AJ
    Park, JW
    Hager, BW
    Brock, MV
    Diener-West, M
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (05) : 460 - 465
  • [2] [Anonymous], 1990, Wkly Epidemiol Rec, V65, P221
  • [3] [Anonymous], 2013, S AFR ANT TREATM GUI
  • [4] [Anonymous], 2012, Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
  • [5] Updated research nosology for HIV-associated neurocognitive disorders
    Antinori, A.
    Arendt, G.
    Becker, J. T.
    Brew, B. J.
    Byrd, D. A.
    Cherner, M.
    Clifford, D. B.
    Cinque, P.
    Epstein, L. G.
    Goodkin, K.
    Gisslen, M.
    Grant, I.
    Heaton, R. K.
    Joseph, J.
    Marder, K.
    Marra, C. M.
    McArthur, J. C.
    Nunn, M.
    Price, R. W.
    Pulliam, L.
    Robertson, K. R.
    Sacktor, N.
    Valcour, V.
    Wojna, V. E.
    [J]. NEUROLOGY, 2007, 69 (18) : 1789 - 1799
  • [6] Berghuis JP, 1999, J ACQ IMMUN DEF SYND, V21, P134
  • [7] The HIV dementia scale: Predictive power in mild dementia and HAART
    Bottiggi, Kara Anne
    Chang, Jason J.
    Schmitt, Frederick A.
    Avison, Malcolm J.
    Mootoor, Yunanan
    Nath, Avindra
    Berger, Joseph R.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2007, 260 (1-2) : 11 - 15
  • [8] CDC, 1987, MMWR S, V36, p1S
  • [9] Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND
    Chalermchai, Thep
    Valcour, Victor
    Sithinamsuwan, Pasiri
    Pinyakorn, Suteeraporn
    Clifford, David
    Paul, Robert H.
    Tipsuk, Somporn
    Fletcher, James L. K.
    DeGruttola, Victor
    Ratto-Kim, Silvia
    Hutchings, Nicholas
    Shikuma, Cecilia
    Ananworanich, Jintanat
    [J]. JOURNAL OF NEUROVIROLOGY, 2013, 19 (02) : 137 - 143
  • [10] Davis Henraya F, 2002, AIDS Read, V12, P29